Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Oligodendroglioma × Neuropsychological Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Hodgkin Disease 1 Glioma 1 Glioblastoma 1 Fatigue 1 Cytokine Release Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

Temozolomide 67 Radiotherapy 31 Carboplatin 21 Bevacizumab 18 Carmustine 15 Irinotecan 14 Vincristine 13 Filgrastim 13 Magnetic Resonance Spectroscopy 11 Surgical Procedures, Operative 10 Procarbazine 10 Erlotinib Hydrochloride 8 Cyclophosphamide 8 Peripheral Blood Stem Cell Transplantation 7 Lomustine 7 Etoposide 7 sargramostim 6 O(6)-benzylguanine 6 Imatinib Mesylate 6 Flucytosine 6 Thiotepa 5 Radiotherapy, Intensity-Modulated 5 Radiation 5 Cisplatin 5 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5 vocimagene amiretrorepvec 4 temsirolimus 4 etoposide phosphate 4 Immunohistochemistry 4 Chemotherapy, Adjuvant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡